Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Ovarian Neoplasms 5Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myeloid, Acute 4Urinary Bladder Neoplasms 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Mantle-Cell 3Lung Neoplasms 3Hematologic Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Waldenstrom Macroglobulinemia 2Thyroid Neoplasms 2Parathyroid Neoplasms 2Otorhinolaryngologic Neoplasms 2Osteosarcoma 2Mixed Tumor, Mesodermal 2Mesothelioma, Cystic 2Mesothelioma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Liposarcoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leiomyosarcoma 2

Interventions

Cytarabine 68fludarabine phosphate 59Peripheral Blood Stem Cell Transplantation 51Cyclophosphamide 48Busulfan 46Tacrolimus 36Mycophenolic Acid 35Etoposide 33Cyclosporine 32Methotrexate 29Whole-Body Irradiation 28Antilymphocyte Serum 28Filgrastim 27Flow Cytometry 22Mitoxantrone 19Radiotherapy 18Daunorubicin 18Melphalan 16Idarubicin 16sargramostim 13Gene Expression Profiling 12Clofarabine 12Polymerase Chain Reaction 11Methylprednisolone 11Decitabine 10Cord Blood Stem Cell Transplantation 10merphos 9Transplantation 9Immunologic Techniques 9Granulocyte Colony-Stimulating Factor 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Congenital Abnormalities × belinostat × Clear all
NCT00357032 2018-04-17

PXD101 in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
12 enrolled 6 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡